Americans with a chronic disease could soon have better access to affordable treatment if a bipartisan bill just passed by the U.S. House makes it through ...

The Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for depemokimab for asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps ...

Asthma sufferers in the UAE who rely on Ventolin to relieve symptoms are struggling to refill their medication, with many ...

Obesity worsens asthma severity and responses to medication, yet most doctors fail to address weight management with these ...

Q: I woke up a few weeks ago unable to catch my breath. It is a scary feeling, and I was freaked out. Fortunately, my wife had an albuterol inhaler handy that she uses for asthma. That seemed to solve ...

non-invasive nasal swab test for kids that diagnoses specific asthma subtype, or endotype, could help clinicians prescribe medications more precisely and pave the way for research toward ...

Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and ...

Despite having the power to set the list price for their medications, pharmaceutical companies are driven by profit and ...

Many Part D prescription drug plans cover Trelegy Ellipta, but costs can vary by plan type and insurer. Read more.

As we approach the first anniversary of omalizumab’s approval for food allergy, its use is “definitely going to grow,” Robert ...

Researchers at the La Jolla Institute for Immunology (LJI) have developed a specific drug "cocktail" that promises to curb severe asthma flare-ups, potentially decreasing the reliance on inhalers ...